Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

期刊论文
出版模式：

开放获取
发表日期：

2024年2月20日

查看全文

Talha Badar,
Ahmad Nanaa,
Ehab Atallah,
Rory M. Shallis,
Sacchi de Camargo Correia Guilherme,
Aaron D. Goldberg,
Antoine N. Saliba,
Anand Patel,
Jan P. Bewersdorf,
Adam S. DuVall,
Danielle Bradshaw,
Yasmin Abaza,
Guru Subramanian Guru Murthy,
Neil Palmisiano,
Amer M. Zeidan,
Vamsi Kota,
Mark R. Litzow

摘要